Cathy Rankin

Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report

Susan M. Chang, John G. Kuhn, H. Ian Robins et al. · Journal of Clinical Oncology · 1999 · 61 citations

Medicine, Oncology, Pharmacology +15

Phase II Trial of Gemcitabine as First Line Chemotherapy in Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Gary V. Burton, Cathy Rankin, Mark M. Zalupski et al. · American Journal of Clinical Oncology · 2006 · 42 citations

Medicine, Oncology, Pharmacology +12

Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia.

Wendy Stock, Tsuong Tsai, Carla Golden et al. · PubMed · 2000 · 33 citations

Life Sciences, Genetics, Molecular Genetics +15

Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid Leukemias

David S. Viswanatha, I‐Ming Chen, Pu Paul Liu et al. · Blood · 1998 · 23 citations · Full text

Medicine, Molecular Biology, Oncology +12

S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors

Charles D. Blanke, Cathy Rankin, Christopher L. Corless et al. · The Oncologist · 2015 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15